CLINICAL SUPPLY REGULATORY ARTICLES

FDA headquarter iStock-1213293784 FDA's Draft Guidance On Safety Testing Of Human Allogeneic Cells For Use In Cell-Based Therapies

This article provides a summary and analysis of the FDA's new draft guidance, Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products. The public comment period ends July 29.

CLINICAL SUPPLY REGULATORY VIDEOS

Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.

Understand how free trade zones work, and explore a flexible and cost efficient way to supply clinical trials in China and around the globe.

In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

Achieving supply chain resilience is crucial, and flexible distribution strategies and ready-to-use depot and logistics networks are instrumental in establishing limitless flexibility and expertise capable of identifying possible risks.

CLINICAL SUPPLY REGULATORY RESOURCES